Drug Type Small molecule drug |
Synonyms BRL-48482, SB 213068, SB-213068 |
Target |
Action agonists |
Mechanism PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists), Insulin sensitizers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H19N3O4S |
InChIKeyZYKPNHFCNSVFNF-UHFFFAOYSA-N |
CAS Registry122320-46-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperglycemia | Preclinical | United Kingdom | 01 Sep 1996 | |
Diabetes Mellitus, Type 2 | Discovery | United Kingdom | - |